SIADH for NP

Syndrome of Inappropriate Antidiuretic Hormone (SIADH) for the Nurse Practitioner Licensing Exam
  • Pathophysiology
    • Excess ADH Secretion: SIADH involves excessive secretion of antidiuretic hormone (ADH), leading to increased water reabsorption by the kidneys despite normal or low plasma osmolality.
SIADH pathophysiology
    • Hyponatremia: The retained water dilutes plasma sodium levels, causing hyponatremia and low plasma osmolality. However, urine remains inappropriately concentrated (high urine osmolality).
    • No Edema: Despite water retention, patients are usually euvolemic without signs of edema or hypervolemia.
  • Etiology
    • CNS Disorders: Head trauma, stroke, meningitis, and brain tumors can disrupt ADH regulation.
    • Pulmonary Conditions: Pneumonia, tuberculosis, and chronic obstructive pulmonary disease (COPD) are common causes.
    • Malignancies: Small-cell lung carcinoma is a classic cause due to ectopic ADH secretion.
    • Medications: Drugs like SSRIs (e.g., fluoxetine), anticonvulsants (e.g., carbamazepine), and chemotherapy agents (e.g., cyclophosphamide) can induce SIADH.
    • Post-Surgical: ADH secretion may increase after major surgery due to stress.
  • Clinical Features
    • Mild Hyponatremia (Na+ 130–135 mEq/L): Often asymptomatic but may cause fatigue, nausea, or headache.
    • Moderate Hyponatremia (Na+ 120–129 mEq/L): Symptoms include confusion, lethargy, and muscle cramps.
    • Severe Hyponatremia (Na+ <120 mEq/L): Neurological symptoms like seizures, altered mental status, and coma due to cerebral edema.
  • Diagnosis
    • Low Serum Sodium (<135 mEq/L) and Low Plasma Osmolality (<275 mOsm/kg).
    • High Urine Osmolality (>100 mOsm/kg) despite hyponatremia.
    • Elevated Urine Sodium (>20–30 mEq/L) with no signs of volume depletion or overload.
    • Normal Renal, Thyroid, and Adrenal Function.
  • Management
    • Fluid Restriction: The primary treatment, limiting fluid intake to 500–1,000 mL/day.
    • Hypertonic Saline (3%): For severe or symptomatic cases, correcting sodium levels slowly to avoid complications.
    • Medications: Vasopressin receptor antagonists (e.g., tolvaptan) and, in refractory cases, demeclocycline to promote free water excretion.
Key Points
  • Pathophysiology: SIADH is caused by excessive ADH secretion, leading to water retention and dilutional hyponatremia.
  • Causes: Include CNS disorders, pulmonary conditions, small-cell lung carcinoma, and certain medications.
  • Symptoms: Range from asymptomatic mild hyponatremia to severe neurological symptoms in cases of marked hyponatremia.
  • Diagnosis: Hyponatremia with low plasma osmolality, high urine osmolality, and normal renal, thyroid, and adrenal function.
  • Treatment: Fluid restriction is first-line, with hypertonic saline used for severe cases.